Safety and Efficacy Study of Pyridostigmine on Patients With Spinal Muscular Atrophy Type 3
Clinical trial NCT02227823 · COMPLETED
Trial details
- NCT number
- NCT02227823
- Sponsor
- Centre Hospitalier Régional de la Citadelle
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-07-01
- Primary completion
- 2017-07-01
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.